Regeneron Pharmaceuticals Inc.

10/19/2024 | Press release | Distributed by Public on 10/20/2024 22:04

Three-year Results for EYLEA HD® (aflibercept) Injection 8 mg Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended Dosing Intervals in Patients[...]